Quarterly report pursuant to Section 13 or 15(d)

Note 11 - Commitments and Contingencies (Details Textual)

v3.21.1
Note 11 - Commitments and Contingencies (Details Textual) - USD ($)
1 Months Ended 3 Months Ended
Apr. 21, 2021
Mar. 16, 2021
Nov. 27, 2019
Apr. 09, 2018
Nov. 02, 2017
Mar. 03, 2017
Dec. 31, 2019
Nov. 30, 2018
Aug. 31, 2018
Nov. 30, 2017
Jun. 30, 2016
Mar. 31, 2020
Mar. 31, 2021
Dec. 31, 2020
Stock Issued During Period, Shares, New Issues (in shares)             2,100,000              
Stockholders' Equity Attributable to Parent, Ending Balance                         $ 4,277,581 $ 1,315,604
Market Capitalization, Fair Value                         $ 57,700,000  
Common Stock [Member]                            
Stock Issued During Period, Shares, New Issues (in shares)                       1,000,001    
Former Chief Executive Officer and President [Member]                            
Common Stock Shares Provided by Agreement (in shares)                 1,175,000          
Common Stock Shares Provided by Agreement, Escrow Period (Month)                 1 year 180 days          
Former Chief Executive Officer and President [Member] | Common Stock [Member]                            
Stock Issued During Period, Shares, New Issues (in shares)               925,000            
Stock Issued During Period, Shares, New Issues Placed in Escrow (in shares)               250,000            
Former Chief Executive Officer and President [Member] | MT [Member] | Common Stock [Member] | Dr. Michael Goldberg [Member]                            
Ownership Percentage                 5.00%          
CRG [Member]                            
Draws on Letter of Credit       $ 7,100,000                    
CRG Loan Agreement, Texas Case [Member] | Judicial Ruling [Member]                            
Loss Contingency, Damages Awarded, Value, Additional Amount           $ 7,000,000                
Loss Contingency, Damages Awarded, Value, Amount not Taken into Consideration                     $ 4,100,000      
Ohio Court of Common Pleas [Member]                            
Litigation Settlement, Amount Awarded from Other Party     $ 4,300,000                      
Litigation Settlement, Reversal of Amount Awarded from Other Party   $ 4,300,000                        
Platinum-Montaur Life Sciences LLC Litigation [Member]                            
Loss Contingency, Damages Sought, Value                   $ 1,900,000        
Platinum-Montaur Life Sciences LLC Litigation [Member] | Pending Litigation [Member]                            
Loss Contingency, Damages Sought, Value         $ 1,900,000                  
New York Litigation Involving Former CEO and President [Member] | Judicial Ruling [Member]                            
Litigation Settlement, Amount Can Be Awarded to Other Party for Indemnification for Attorneys’ Fees $ 14,955                          
Litigation Settlement, Amount Can Be Advanced to Other Party for Attorneys’ Fees Subject to Repayment $ 1,237.50                          
CRG [Member] | Term Loan Agreement [Member] | CRG Loan Agreement, Texas Case [Member] | Judicial Ruling [Member]                            
Repayments of Debt           59,000,000                
CRG [Member] | Term Loan Agreement [Member] | Maximum [Member]                            
Debt Instrument, Agreed-upon Final Payoff Amount           $ 66,000,000